Copyright Reports & Markets. All rights reserved.

Global Biologics Drug Discovery Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Biologics Drug Discovery Market Overview

    • 1.1 Product Overview and Scope of Biologics Drug Discovery
    • 1.2 Classification of Biologics Drug Discovery by Types
      • 1.2.1 Global Biologics Drug Discovery Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Biologics Drug Discovery Revenue Market Share by Types in 2018
      • 1.2.3 Biologicals
      • 1.2.4 Monoclonal Antibodies
      • 1.2.5 Recombinant Proteins
      • 1.2.6 Other Biologics
    • 1.3 Global Biologics Drug Discovery Market by Application
      • 1.3.1 Global Biologics Drug Discovery Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospitals
      • 1.3.3 Clinics
      • 1.3.4 Research Labs
      • 1.3.5 Diagnostic Centers
      • 1.3.6 Others
    • 1.4 Global Biologics Drug Discovery Market by Regions
      • 1.4.1 Global Biologics Drug Discovery Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Biologics Drug Discovery Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Biologics Drug Discovery Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biologics Drug Discovery Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Biologics Drug Discovery Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biologics Drug Discovery Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Biologics Drug Discovery (2014-2024)

    2 Manufacturers Profiles

    • 2.1 GenScript
      • 2.1.1 Business Overview
      • 2.1.2 Biologics Drug Discovery Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 GenScript Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Roche
      • 2.2.1 Business Overview
      • 2.2.2 Biologics Drug Discovery Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Roche Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Pfizer
      • 2.3.1 Business Overview
      • 2.3.2 Biologics Drug Discovery Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Pfizer Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Novartis
      • 2.4.1 Business Overview
      • 2.4.2 Biologics Drug Discovery Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Novartis Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Sanofi
      • 2.5.1 Business Overview
      • 2.5.2 Biologics Drug Discovery Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Sanofi Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Merck
      • 2.6.1 Business Overview
      • 2.6.2 Biologics Drug Discovery Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Merck Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 GlaxoSmithKline
      • 2.7.1 Business Overview
      • 2.7.2 Biologics Drug Discovery Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 GlaxoSmithKline Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 AstraZeneca
      • 2.8.1 Business Overview
      • 2.8.2 Biologics Drug Discovery Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 AstraZeneca Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 AbbVie
      • 2.9.1 Business Overview
      • 2.9.2 Biologics Drug Discovery Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 AbbVie Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Amgen
      • 2.10.1 Business Overview
      • 2.10.2 Biologics Drug Discovery Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Amgen Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Bristol-Myers Squibb
      • 2.11.1 Business Overview
      • 2.11.2 Biologics Drug Discovery Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Bristol-Myers Squibb Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Novo Nordisk
      • 2.12.1 Business Overview
      • 2.12.2 Biologics Drug Discovery Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Novo Nordisk Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Allergan
      • 2.13.1 Business Overview
      • 2.13.2 Biologics Drug Discovery Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Allergan Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Astellas Pharma
      • 2.14.1 Business Overview
      • 2.14.2 Biologics Drug Discovery Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Astellas Pharma Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Teva Pharmaceutical Industries
      • 2.15.1 Business Overview
      • 2.15.2 Biologics Drug Discovery Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Teva Pharmaceutical Industries Biologics Drug Discovery Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Biologics Drug Discovery Market Competition, by Players

    • 3.1 Global Biologics Drug Discovery Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Biologics Drug Discovery Players Market Share
      • 3.2.2 Top 10 Biologics Drug Discovery Players Market Share
    • 3.3 Market Competition Trend

    4 Global Biologics Drug Discovery Market Size by Regions

    • 4.1 Global Biologics Drug Discovery Revenue and Market Share by Regions
    • 4.2 North America Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 4.5 South America Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Biologics Drug Discovery Revenue and Growth Rate (2014-2019)

    5 North America Biologics Drug Discovery Revenue by Countries

    • 5.1 North America Biologics Drug Discovery Revenue by Countries (2014-2019)
    • 5.2 USA Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Biologics Drug Discovery Revenue and Growth Rate (2014-2019)

    6 Europe Biologics Drug Discovery Revenue by Countries

    • 6.1 Europe Biologics Drug Discovery Revenue by Countries (2014-2019)
    • 6.2 Germany Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 6.3 UK Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 6.4 France Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Biologics Drug Discovery Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Biologics Drug Discovery Revenue by Countries

    • 7.1 Asia-Pacific Biologics Drug Discovery Revenue by Countries (2014-2019)
    • 7.2 China Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 7.5 India Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Biologics Drug Discovery Revenue and Growth Rate (2014-2019)

    8 South America Biologics Drug Discovery Revenue by Countries

    • 8.1 South America Biologics Drug Discovery Revenue by Countries (2014-2019)
    • 8.2 Brazil Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Biologics Drug Discovery Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Biologics Drug Discovery by Countries

    • 9.1 Middle East and Africa Biologics Drug Discovery Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Biologics Drug Discovery Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Biologics Drug Discovery Revenue and Growth Rate (2014-2019)

    10 Global Biologics Drug Discovery Market Segment by Type

    • 10.1 Global Biologics Drug Discovery Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Biologics Drug Discovery Market Forecast by Type (2019-2024)
    • 10.3 Biologicals Revenue Growth Rate (2014-2024)
    • 10.4 Monoclonal Antibodies Revenue Growth Rate (2014-2024)
    • 10.5 Recombinant Proteins Revenue Growth Rate (2014-2024)
    • 10.6 Other Biologics Revenue Growth Rate (2014-2024)

    11 Global Biologics Drug Discovery Market Segment by Application

    • 11.1 Global Biologics Drug Discovery Revenue Market Share by Application (2014-2019)
    • 11.2 Biologics Drug Discovery Market Forecast by Application (2019-2024)
    • 11.3 Hospitals Revenue Growth (2014-2019)
    • 11.4 Clinics Revenue Growth (2014-2019)
    • 11.5 Research Labs Revenue Growth (2014-2019)
    • 11.6 Diagnostic Centers Revenue Growth (2014-2019)
    • 11.7 Others Revenue Growth (2014-2019)

    12 Global Biologics Drug Discovery Market Size Forecast (2019-2024)

    • 12.1 Global Biologics Drug Discovery Market Size Forecast (2019-2024)
    • 12.2 Global Biologics Drug Discovery Market Forecast by Regions (2019-2024)
    • 12.3 North America Biologics Drug Discovery Revenue Market Forecast (2019-2024)
    • 12.4 Europe Biologics Drug Discovery Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Biologics Drug Discovery Revenue Market Forecast (2019-2024)
    • 12.6 South America Biologics Drug Discovery Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Biologics Drug Discovery Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization.

      Scope of the Report:
      The global Biologics Drug Discovery market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biologics Drug Discovery.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Biologics Drug Discovery market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biologics Drug Discovery market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      GenScript
      Roche
      Pfizer
      Novartis
      Sanofi
      Merck
      GlaxoSmithKline
      AstraZeneca
      AbbVie
      Amgen
      Bristol-Myers Squibb
      Novo Nordisk
      Allergan
      Astellas Pharma
      Teva Pharmaceutical Industries

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Biologicals
      Monoclonal Antibodies
      Recombinant Proteins
      Other Biologics

      Market Segment by Applications, can be divided into
      Hospitals
      Clinics
      Research Labs
      Diagnostic Centers
      Others

      Buy now